Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Gastroenterology

Beyond the Colon: Stomach, Duodenum, and Thyroid Surveillance

At a Glance

For patients with Gardner syndrome, whole-body surveillance is essential after managing colon health. Regular endoscopies (EGDs) monitor the stomach and duodenum for polyps using the Spigelman staging system, while annual thyroid ultrasounds detect early signs of thyroid cancer.

Once the colon is proactively managed, the focus of Gardner syndrome care shifts to other areas of the body that require lifelong attention. The most critical “secondary” areas are the upper gastrointestinal (GI) tract (the stomach and duodenum) and the thyroid gland [1][2].

Because the APC gene mutation is present in every cell, your care team must use a “whole-body” lens to ensure that small changes in these organs are caught and managed early [3][4].

When Do Screenings Begin?

It helps to have a mental map of when these secondary screenings will enter your life.

Screening Type Body Area Starting Age Frequency
Colonoscopy Colon Age 10–12 Every 1–2 years [5]
EGD (Endoscopy) Stomach/Duodenum Age 20–25 Based on Spigelman stage [6][4]
Ultrasound Thyroid Varies (often teens/20s) Annually [2][4]

(Note: These are general guidelines; your specific timeline may vary based on your mutation and family history).

Upper GI Surveillance: The EGD

The duodenum (the first part of the small intestine just past the stomach) is a common site for polyp growth in Gardner syndrome [1]. To monitor this, you will have regular Esophagogastroduodenoscopy (EGD)—a procedure where a thin camera is passed down the throat while you are sedated.

  • When it starts: Current guidelines recommend starting EGD surveillance between ages 20 to 25, or prior to your colon surgery [6][4].
  • The Spigelman Classification: To decide how often you need an EGD, doctors use the Spigelman staging system [7][8]. This system assigns points based on four factors:
    1. The number of polyps.
    2. The size of the largest polyp.
    3. The appearance of the cells under a microscope (histology).
    4. The presence of advanced cell changes (dysplasia) [9][10].

Understanding Your Spigelman Score

The score translates into a “stage” from 0 to IV, which dictates your follow-up [11][12]:

  • Stage 0–II: Generally considered low risk; screenings may be every several years [13].
  • Stage III: Moderate risk; screenings become more frequent (often every 6–12 months) [11].
  • Stage IV: High risk; at this stage, doctors may discuss pancreas-sparing duodenectomy—a specialized surgery to remove the duodenum while leaving the pancreas intact—to prevent cancer before it starts [11][8][14].

Gastric (Stomach) Polyps

It is very common for patients with Gardner syndrome to have “carpeting” polyps in the stomach called fundic gland polyps [15]. While these are almost always benign (non-cancerous), your doctor will monitor them for any “atypical” growth, particularly in the upper section of the stomach [16][17].

Thyroid Surveillance

People with Gardner syndrome/FAP have an increased risk of a specific type of thyroid cancer called cribriform-morular thyroid carcinoma [18][19].

  • Who is at risk: While anyone can be affected, this risk is significantly higher for females, particularly those in their 20s and 30s [2][20].
  • The Screening Tool: Current guidelines recommend an annual thyroid ultrasound [2][4]. An ultrasound is a painless, non-invasive test that can find small nodules long before they can be felt by a doctor during a physical exam [18][20].
  • The Prognosis: When caught early through screening, the prognosis for FAP-associated thyroid cancer is typically excellent.

Building Your Multi-Specialty Team

Managing Gardner syndrome requires more than just one doctor. Your “comprehensive care team” should ideally include:

  1. A Gastroenterologist with expertise in high-risk polyposis.
  2. A Colorectal Surgeon for preventative colon care.
  3. An Endocrinologist for thyroid monitoring.
  4. A Genetic Counselor to help with family testing and result interpretation.

By following this comprehensive roadmap, you are not just managing a syndrome—you are actively protecting your future health across every system in your body [21][4].

Common questions in this guide

At what age should I start getting upper GI screenings for Gardner syndrome?
Current guidelines recommend starting regular endoscopy (EGD) surveillance between the ages of 20 and 25, or prior to your colon surgery. Your doctor will use these screenings to check for polyps and determine how often future endoscopies are needed.
What is the Spigelman classification system?
The Spigelman staging system helps doctors assess your risk for duodenal cancer by evaluating the number, size, and cell features of your polyps. It assigns a stage from 0 to IV, which tells your gastroenterologist whether you need an endoscopy every few years, or more frequently.
Are the polyps in my stomach dangerous?
It is very common for people with Gardner syndrome to have many fundic gland polyps in their stomach. These are almost always benign and non-cancerous, but your doctor will continue to monitor them during routine endoscopies to ensure no atypical growth occurs.
Do I need regular screenings for thyroid cancer?
Yes, individuals with Gardner syndrome, especially females, have a higher risk of developing a specific type of thyroid cancer. Current guidelines recommend getting a painless thyroid ultrasound every year to detect any small nodules early.
What happens if my duodenal polyps reach Spigelman Stage IV?
Stage IV indicates a high risk for cancer development. At this stage, your care team may discuss a pancreas-sparing duodenectomy, which is a proactive surgery that removes the at-risk duodenum while safely leaving the pancreas intact.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my current Spigelman stage, and how does it change our plan for my next EGD?
  2. 2.Are the polyps in my stomach 'fundic gland polyps,' and do they require biopsy or removal?
  3. 3.Given that I am female [if applicable], should we schedule my first thyroid ultrasound now?
  4. 4.If my duodenal polyps reach Stage IV, what are the criteria for moving from endoscopic removal to a pancreas-sparing surgery?
  5. 5.Who is the upper GI specialist on my team who has experience with FAP-specific duodenal management?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    A neoepitope derived from a novel human germline APC gene mutation in familial adenomatous polyposis shows selective immunogenicity.

    Majumder S, Shah R, Elias J, et al.

    PloS one 2018; (13(9)):e0203845 doi:10.1371/journal.pone.0203845.

    PMID: 30256815
  2. 2

    Prevalence of and risk factors for thyroid carcinoma in patients with familial adenomatous polyposis: results of a multicenter study in Japan and a systematic review.

    Sada H, Hinoi T, Ueno H, et al.

    Surgery today 2019; (49(1)):72-81 doi:10.1007/s00595-018-1710-3.

    PMID: 30182306
  3. 3

    Endoscopic Management and Surgical Considerations for Familial Adenomatous Polyposis.

    Stanich PP, Sullivan B, Kim AC, Kalady MF

    Gastrointestinal endoscopy clinics of North America 2022; (32(1)):113-130 doi:10.1016/j.giec.2021.08.007.

    PMID: 34798980
  4. 4

    Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revision.

    Zaffaroni G, Mannucci A, Koskenvuo L, et al.

    The British journal of surgery 2024; (111(5)) doi:10.1093/bjs/znae070.

    PMID: 38722804
  5. 5

    Genetic Syndromes Associated with Gastric Cancer.

    Kim W, Kidambi T, Lin J, Idos G

    Gastrointestinal endoscopy clinics of North America 2022; (32(1)):147-162 doi:10.1016/j.giec.2021.08.004.

    PMID: 34798983
  6. 6

    Upper GI involvement in children with familial adenomatous polyposis syndrome: single-center experience and meta-analysis of the literature.

    Gutierrez Sanchez LH, Alsawas M, Stephens M, et al.

    Gastrointestinal endoscopy 2018; (87(3)):648-656.e3 doi:10.1016/j.gie.2017.10.043.

    PMID: 29122597
  7. 7

    Risks, Benefits, and Effects on Management for Biopsy of the Papilla in Patients With Familial Adenomatous Polyposis.

    Mehta NA, Shah RS, Yoon J, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021; (19(4)):760-767 doi:10.1016/j.cgh.2020.05.054.

    PMID: 32492482
  8. 8

    Spigelman stage IV duodenal polyposis does not precede most duodenal cancer cases in patients with familial adenomatous polyposis.

    Thiruvengadam SS, Lopez R, O'Malley M, et al.

    Gastrointestinal endoscopy 2019; (89(2)):345-354.e2 doi:10.1016/j.gie.2018.07.033.

    PMID: 30081000
  9. 9

    The Spigelman Staging System and the Risk of Duodenal and Papillary Cancer in Familial Adenomatous Polyposis: A Systematic Review and Meta-Analysis.

    Mannucci A, Puzzono M, Goel A, et al.

    The American journal of gastroenterology 2024; (119(4)):617-624 doi:10.14309/ajg.0000000000002688.

    PMID: 38294150
  10. 10

    The impact of chromoendoscopy for surveillance of the duodenum in patients with MUTYH-associated polyposis and familial adenomatous polyposis.

    Hurley JJ, Thomas LE, Walton SJ, et al.

    Gastrointestinal endoscopy 2018; (88(4)):665-673 doi:10.1016/j.gie.2018.04.2347.

    PMID: 29702101
  11. 11

    Pancreas- and Pylorus-Preserving Duodenectomy for Advanced Familial Duodenal Polyposis.

    Leite JS, Tralhão JG, Manso A, et al.

    GE Portuguese journal of gastroenterology 2020; (27(3)):185-191 doi:10.1159/000503010.

    PMID: 32509924
  12. 12

    Endoscopic management of duodenal adenomatosis in familial adenomatous polyposis-A case-based review.

    Soons E, Bisseling TM, van Kouwen MCA, et al.

    United European gastroenterology journal 2021; (9(4)):461-468 doi:10.1002/ueg2.12071.

    PMID: 34529357
  13. 13

    Pancreas preserving duodenectomy for duodenal polyposis in familial adenomatous polyposis.

    Lindemann J, Krige JEJ, Jonas E

    South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie 2020; (58(3)):161.

    PMID: 33231011
  14. 14

    Tailored surgical treatment of duodenal polyposis in familial adenomatous polyposis syndrome.

    Augustin T, Moslim MA, Tang A, Walsh RM

    Surgery 2018; (163(3)):594-599 doi:10.1016/j.surg.2017.10.035.

    PMID: 29331402
  15. 15

    Gastric cancer in FAP: a concerning rise in incidence.

    Mankaney G, Leone P, Cruise M, et al.

    Familial cancer 2017; (16(3)):371-376 doi:10.1007/s10689-017-9971-3.

    PMID: 28185118
  16. 16

    The challenge of preventing gastric cancer in patients under surveillance for familial adenomatous polyposis.

    Bouchiba H, Aelvoet AS, van Grieken NCT, et al.

    Familial cancer 2025; (24(1)):14 doi:10.1007/s10689-024-00438-4.

    PMID: 39776297
  17. 17

    Risk factors for dysplastic lesions in the proximal stomach in patients with familial adenomatous polyposis.

    Bouchiba H, Aelvoet AS, Bastiaansen BAJ, et al.

    Endoscopy international open 2025; (13()):a27313533 doi:10.1055/a-2731-3533.

    PMID: 41216620
  18. 18

    Cribriform morular thyroid carcinoma: a recently reclassified entity.

    Chang HY, Lim MY, Bundele MM

    ANZ journal of surgery 2023; (93(9)):2257-2259 doi:10.1111/ans.18451.

    PMID: 37020332
  19. 19

    Clinicopathological and molecular mechanisms of cribriform morular thyroid carcinoma: a case report and a literature review.

    Zhang X, Lv Y, Yan W, et al.

    Annals of medicine and surgery (2012) 2025; (87(12)):8944-8948 doi:10.1097/MS9.0000000000004082.

    PMID: 41377377
  20. 20

    Thyroid Nodules in Children With Familial Adenomatous Polyposis.

    Smith JR, Kamihara J, Church AJ, et al.

    The American journal of gastroenterology 2022; (117(7)):1166-1168 doi:10.14309/ajg.0000000000001747.

    PMID: 35333786
  21. 21

    Current management of familial adenomatous polyposis.

    Lauricella S, Rausa E, Pellegrini I, et al.

    Expert review of anticancer therapy 2024; (24(6)):363-377 doi:10.1080/14737140.2024.2344649.

    PMID: 38785081

This page provides general educational information about screening and surveillance for Gardner syndrome. It does not replace professional medical advice. Always work with your gastroenterologist and multi-specialty care team to determine your personal screening schedule.

Get notified when new evidence is published on Gardner syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.